RIPK2 Antibody - middle region : FITC (AVARP02047_P050-FITC)

RIPK2 is a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. It contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli.This gene encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.

RIPK2; XIAP; UBC; TRAF3; KDM3A; PRMT2; PELI3; NOD1; MAP3K7; CHUK; LRRK2; NOD2; TRAF4; TRAF6; MAP3K4; CASP12; NAT16; RNF31; RIPK1; MAVS; TRAF2; TAB2; TAB1; IKBKG; BIRC3; BIRC2; CARD16; CARD6; UBE2I; SMURF1; CFLAR; BCL10; TLR4; TLR2; TRAF5; CASP8; TRAF1; SM

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.